MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

24 hedge funds and large institutions have $10.3M invested in Marinus Pharmaceuticals, Inc in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 8 closing their positions.

Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Jennison Associates
1
Jennison Associates
New York
$1.11M
2
JGC
2
J. Goldman & Co
New York
$533K
3
ARTA
3
A.R.T. Advisors
New York
$66K
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$6K
5
TRCT
5
Tower Research Capital (TRC)
New York
$7K

Top Sellers

1
NC
1
Nexthera Capital
New York
$685K
2
VKH
2
Virtu KCG Holdings
New York
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$800K
4
BlackRock
4
BlackRock
New York
$228K
5
PAM
5
Panagora Asset Management
Massachusetts
$5K
Name Market Value Shares Shares
Change 		Shares
Change %
TDC
26
Thompson Davis & Co
Virginia
– – -13,000 Closed
CGT
27
Capital Guardian Trust
California
– – -4,120 Closed
AIM
28
Acrospire Investment Management
Illinois
– – -1,697 Closed
Deutsche Bank
29
Deutsche Bank
Germany
$0 159 -341 -68%
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– – -161 Closed
Bank of America
31
Bank of America
North Carolina
– – -2 Closed
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$0 4 +4 New
1
2